EU Power and Stem Cells

Frontlines | EU Power and Stem Cells Courtesy of Dennis Steindler A bit of a tussle is happening in the European Union over which official body can ban, or not ban, human embryonic stem cell research. The familiar ethical controversies are mixed with considerable legal confusion. A report released this month by the European Commission, which directs EU-funded research, says regulation of the research is in the hands of member states. However, the European Parliament voted to ban some forms

Written byAndrew Scott
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A bit of a tussle is happening in the European Union over which official body can ban, or not ban, human embryonic stem cell research. The familiar ethical controversies are mixed with considerable legal confusion.

A report released this month by the European Commission, which directs EU-funded research, says regulation of the research is in the hands of member states. However, the European Parliament voted to ban some forms of such research in April. "Regulating on ethical matters is the [jurisdiction] of the member states," says EU Research Commissioner Philippe Busquin, introducing the Commission's latest survey of the field. The EU, however, can legislate on matters of quality and safety. So research opponents have added amendments about stem cells to a quality and safety legislation proposal.

European Parliament member David Bowe says that such confusions are "part of the natural tension. You never know quite what European legislation you've got ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies